Anlotinib Active Not Recruiting Phase 2 Trials for Neoplasm of Bone Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03527888Study of Anlotinib in Patients With Primary Malignant Bone Tumors